Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More information6th April 2022
ICH guideline Q2(R2) on validation of analytical procedures - Public Consultation
This guideline applies to new or revised analytical procedures used for release and stability ICH Q2(R2) Guideline testing of commercial drug substances and products (chemical and biological/biotechnological). The guideline can also be applied to other analytical procedures used as part of the control strategy (ICH Q8-Q10) following a risk-based approach. The scientific principles described in this guideline can be applied in a phase-appropriate manner during clinical development. This guideline may also be applicable to other types of products, with appropriate regulatory authority consultation as needed.
Comments should be provided using this template and sent to ich@ema.europa.euby 31 July 2022.